GANX GAIN THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - Underwriting Agreement Gain Therapeutics, Inc. entered into an underwriting agreement for the offering, issuance, and sale of shares of common stock and pre-funded warrants, with expected net proceeds of approximately $10.1 million.Get access to all SEC 8-K filings of the GAIN THERAPEUTICS INC